# Targeting Platelets in Chronic HIV Infection

> **NCT02578706** · PHASE2 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 27 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02578706
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578706, "Targeting Platelets in Chronic HIV Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02578706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*